Telehealth Advocates Praise DEA's 3rd Extension of Telemedicine Flexibilities, but Call for Further Action - MedCity News
The DEA's extension of telehealth prescribing for controlled substances was welcomed, but advocates stress the need for permanent solutions to ensure ongoing access.